First-in-human phase I study of the CD40 agonist mAb CDX-1140 and in combination with CDX-301 (rhFLT3L) in patients with advanced cancers: Interim results Meeting Abstract
| Authors: | Sanborn, R. E.; Gabrail, N. Y.; Bhardwaj, N.; Gordon, M. S.; O'Hara, M.; Khalil, D.; Hawthorne, T.; Gedrich, R.; Vitale, L.; Rogalski, M.; Li, T.; Rawls, T.; Keler, T.; Yellin, M. |
| Abstract Title: | First-in-human phase I study of the CD40 agonist mAb CDX-1140 and in combination with CDX-301 (rhFLT3L) in patients with advanced cancers: Interim results |
| Meeting Title: | 110th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 79 |
| Issue: | 13 Suppl. |
| Meeting Dates: | 2019 Mar 29-Apr 3 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2019-07-01 |
| Language: | English |
| ACCESSION: | WOS:000488129900379 |
| DOI: | 10.1158/1538-7445.Am2019-lb-194 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LB-194 -- Source: Wos |
